BICLUSTER_ID : UPREG-62
PATHOGENS /3/ : escherichia coli,mycobacterium tuberculosis,streptococcus pyogenes
TARGETS /33/ : HCK, GCH1, IGFBP3, SAT1, CXCL10, CFB, NFKB1, JAK2, CCL8, IL1B, CASP1, ICAM1, PLA2G4A, GCLM, CCL20, CCL2, CD40, CD80, TNFRSF1B, CASP7, VCAM1, CCL5, PIM1, TXNRD1, S100A11, STAT1, IL12B, WARS, TAP1, IFNGR2, IL2RG, IL6, PLAUR
Gene SetLeading Edge Genes
NETPATH TNF ALPHA PATHWAY UPPSMB8, PSME2, NFKBIA, GCH1, CXCL2, CXCL10, PSME1, C2, CASP4, IFITM1, TNIP1, CXCL1, CSF1, JUNB, BCL3, TNFSF10, GBP2, IFITM3, TNFAIP2, TNFRSF9, IL1B, IL15RA, ICAM1, IRF1, BID, NFKB2, STAT4, NFKBIE, CCL2, ISGF3G, TMSB10, TNFRSF1B, CASP7, TRAF1, CXCL11, IFIT2, IER3, S100A11, BIRC3, KLF10, WARS, IFNGR2, TRIM21, IL6, IFI27, MX1, PLAUR
NETPATH IL 2 PATHWAY UPNMI, RGS16, IFI44, BHLHB2, NFKB1, IFIT1, SP100, TNFSF10, GADD45G, IFITM3, IL1B, ICAM1, CASP1, IRF1, UPP1, AHR, GBP1, STAT4, ISGF3G, TNFRSF1B, TRAFD1, PIM1, TXNRD1, IER3, STAT1, KLF6, WARS, TRIM21, IL2RG, IL6, MX1, PLAUR
NETPATH IL 1 PATHWAY UPBIRC3, CCL20, CXCL1, WARS, CCL2, CCL8, IL6, IL1B, ICAM1, CXCL2, TXNRD1, CFB
NETPATH KIT RECEPTOR PATHWAY UPPLA2G4A, MCL1, JUNB, CCL2, TAP1, IL2RG, IL6, CCL5, PIM1, TXNRD1, IER3
NCI IL23PATHWAYNFKB1, STAT1, IL12B, JAK2, CXCL1, STAT4, CCL2, IL18R1, RELA, NFKBIA, IL6, IL1B, STAT3
NCI IL12 2PATHWAYNFKB1, STAT1, IL12B, GADD45B, JAK2, NFKB2, STAT4, IL18R1, GADD45G, RELA, IL2RG, IL1B, STAT3
NETPATH IL 5 PATHWAY UPNFKB1, GCLM, PLSCR1, BIRC3, NFKB2, NFKBIE, CCL2, TBK1, IL1B, ICAM1, PIM1, UPP1, NFE2L2, IER3, MYD88, CASP4
NETPATH B CELL RECEPTOR PATHWAY UPIFITM1, UBE2L6, BIRC3, MCL1, CCL2, HCK, EIF2AK2, NMI, TRAF1, IGFBP3, ICAM1, DUSP8, PIM1, MYD88
NETPATH IL 4 PATHWAY DOWNSTAT1, UBE2L6, CCL20, GADD45B, LITAF, CCL2, TNFSF10, GBP2, NFKBIA, TLR3, ICAM1, IRF1, CXCL2, MX1
NETPATH IL 7 PATHWAY UPLITAF, CXCL1, MCL1, CCL8, CCL5, CXCL2, CD80
GERY CEBP TARGETSGADD45B, GCH1, JUNB, PIM1, SAT1, GADD45G
NCI IL6 7PATHWAYSTAT1, CEBPD, JAK2, MCL1, CEBPB, JUNB, HCK, STAT3, IRF1
NETPATH IL 3 PATHWAY UPIL1B, CSF1, MCL1, CCL2, PIM1
SA MMP CYTOKINE CONNECTIONCSF1, IL1B, SELL, TNFRSF1B
NCI IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELLIFITM1, VCAM1, SELL, CD81, B2M, CD40
NETPATH IL 6 PATHWAY UPSTAT1, GADD45B, MCL1, JUNB, CEBPB, BCL3, MAP3K8, NMI, IRF1, PIM1, MX1
BIOCARTA IL10 PATHWAY
RASHI RESPONSE TO IONIZING RADIATION 6
BIOCARTA STEM PATHWAY
NETPATH IL 9 PATHWAY UP
BIOCARTA NFKB PATHWAY
MAHAJAN RESPONSE TO IL1A UP
BIOCARTA IL6 PATHWAY
KEGG GRAFT VERSUS HOST DISEASE
LINDSTEDT DENDRITIC CELL MATURATION B
KRASNOSELSKAYA ILF3 TARGETS UP
NCI HOST INTERACTIONS OF HIV FACTORS
RASHI RESPONSE TO IONIZING RADIATION 2
RADAEVA RESPONSE TO IFNA1 UP
CORUM PA28 COMPLEX
BOWIE RESPONSE TO EXTRACELLULAR MATRIX
MUNSHI MULTIPLE MYELOMA UP
NCI SCF SKP2 MEDIATED DEGRADATION OF P27 P21
REACTOME SCF SKP2 MEDIATED DEGRADATION OF P27 P21
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP
LENAOUR DENDRITIC CELL MATURATION DN
HINATA NFKB TARGETS KERATINOCYTE UP
MARKEY RB1 ACUTE LOF UP
SCHEIDEREIT IKK INTERACTING PROTEINS
XU AKT1 TARGETS 6HR
POOLA INVASIVE BREAST CANCER UP
LIU VAV3 PROSTATE CARCINOGENESIS UP
REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES
SEITZ NEOPLASTIC TRANSFORMATION BY 8P DELETION UP
BROWNE HCMV INFECTION 6HR UP
DAUER STAT3 TARGETS DN
BIOCARTA RANKL PATHWAY
MCLACHLAN DENTAL CARIES UP
WHITESIDE CISPLATIN RESISTANCE UP
HOSHIDA LIVER CANCER SUBCLASS S1
DIRMEIER LMP1 RESPONSE LATE DN
LEE LIVER CANCER E2F1 UP
HELLER SILENCED BY METHYLATION UP
BOWIE RESPONSE TO TAMOXIFEN
ZHOU INFLAMMATORY RESPONSE LPS UP
SMID BREAST CANCER LUMINAL B DN
ICHIBA GRAFT VERSUS HOST DISEASE 35D UP
FURUKAWA DUSP6 TARGETS PCI35 UP
REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL
BIOCARTA IL17 PATHWAY
VERHAAK AML WITH NPM1 MUTATED UP
BROCKE APOPTOSIS REVERSED BY IL6
REACTOME G ALPHA I SIGNALLING EVENTS
TIAN TNF SIGNALING VIA NFKB
HUMMEL BURKITTS LYMPHOMA DN
KEGG TOLL LIKE RECEPTOR SIGNALING PATHWAY
NCI VIF MEDIATED DEGRADATION OF APOBEC3G
GOLUB ALL VS AML DN
CORUM NFKB1-NFKB2-REL-RELA-RELB COMPLEX
NCI DEGRADATION OF BETA CATENIN BY THE DESTRUCTION COMPLEX
LEE EARLY T LYMPHOCYTE DN
HUANG DASATINIB RESISTANCE UP
HINATA NFKB TARGETS FIBROBLAST UP
MISSIAGLIA REGULATED BY METHYLATION UP
KEGG PRIMARY IMMUNODEFICIENCY
ZHANG INTERFERON RESPONSE
CHANG IMMORTALIZED BY HPV31 DN
SIMBULAN UV RESPONSE NORMAL UP
KHETCHOUMIAN TRIM24 TARGETS UP
KIM LRRC3B TARGETS
DACOSTA ERCC3 ALLELE XPCS VS TTD UP
CORUM PA28-20S PROTEASOMEPSME2, PSME1
ZHANG ANTIVIRAL RESPONSE TO RIBAVIRIN UP
RUTELLA RESPONSE TO CSF2RB AND IL4 DN
BIOCARTA TH1TH2 PATHWAY
TSAI DNAJB4 TARGETS UP
MORI PRE BI LYMPHOCYTE DN
DER IFN BETA RESPONSE UP
DEBIASI APOPTOSIS BY REOVIRUS INFECTION UP
NETPATH IL 6 PATHWAY
GILDEA METASTASIS
AMIT EGF RESPONSE 20 HELA
GALI TP53 TARGETS APOPTOTIC UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 10D DN
HOUSTIS ROS
BASSO CD40 SIGNALING UP
MARZEC IL2 SIGNALING UP
BIOCARTA BLYMPHOCYTE PATHWAY
BOYLAN MULTIPLE MYELOMA C D DN
WANG ESOPHAGUS CANCER VS NORMAL UP
WU HBX TARGETS 2 DN
MAHADEVAN RESPONSE TO MP470 UP
CORUM UBIQUITIN E3 LIGASE TRIM25 DDX58
SMID BREAST CANCER NORMAL LIKE UP
BIOCARTA TID PATHWAY
KEGG RIG I LIKE RECEPTOR SIGNALING PATHWAY
SANA RESPONSE TO IFNG UP
REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G
KEGG LEISHMANIA INFECTION
BOYLAN MULTIPLE MYELOMA PCA1 UP
LIANG SILENCED BY METHYLATION UP
BIOCARTA DEATH PATHWAY
SEKI INFLAMMATORY RESPONSE LPS UP
DAZARD UV RESPONSE CLUSTER G24
GRAHAM CML QUIESCENT VS CML DIVIDING UP
PARK TRETINOIN RESPONSE AND PML RARA FUSION
MOSERLE IFNA RESPONSE
NCI UBIQUITIN DEPENDENT DEGRADATION OF CYCLIN D1
FOSTER INFLAMMATORY RESPONSE LPS UP
BIOCARTA ASBCELL PATHWAY
RODWELL AGING KIDNEY UP
INGA TP53 TARGETS
KEGG CYTOSOLIC DNA SENSING PATHWAY
LINDSTEDT DENDRITIC CELL MATURATION C
MORI IMMATURE B LYMPHOCYTE UP
HESS TARGETS OF HOXA9 AND MEIS1 DN
BIOCARTA TOLL PATHWAY
AMIT EGF RESPONSE 120 MCF10A
BERTUCCI MEDULLARY VS DUCTAL BREAST CANCER UP
NCI UBIQUITIN MEDIATED DEGRADATION OF PHOSPHORYLATED CDC25A
NCI ACTIVATION OF PRO CASPASE 8
PRAMOONJAGO SOX4 TARGETS UP
NETPATH IL 5 PATHWAY
BIOCARTA NO2IL12 PATHWAY
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 16D UP
BOYAULT LIVER CANCER SUBCLASS G5 DN
ICHIBA GRAFT VERSUS HOST DISEASE D7 UP
MUELLER COMMON TARGETS OF AML FUSIONS DN
TENEDINI MEGAKARYOCYTE MARKERS
LINDSTEDT DENDRITIC CELL MATURATION A
HOFMANN CELL LYMPHOMA DN
MORI LARGE PRE BII LYMPHOCYTE DN
XU HGF TARGETS REPRESSED BY AKT1 UP
BIOCARTA NKT PATHWAY
BROWNE INTERFERON RESPONSIVE GENES
REACTOME SIGNALING IN IMMUNE SYSTEM
ROETH TERT TARGETS UP
ST TYPE I INTERFERON PATHWAY
KAAB FAILED HEART VENTRICLE DN
KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY
OSADA ASCL1 TARGETS DN
GILMORE CORE NFKB PATHWAY
NUYTTEN EZH2 TARGETS UP
DUTTA APOPTOSIS VIA NFKB
BIOCARTA IL22BP PATHWAY
DELYS THYROID CANCER UP
TSAI RESPONSE TO IONIZING RADIATION
DIRMEIER LMP1 RESPONSE EARLY
DER IFN GAMMA RESPONSE UP
KEGG INTESTINAL IMMUNE NETWORK FOR IGA PRODUCTION
NCI VPU MEDIATED DEGRADATION OF CD4
BENNETT SYSTEMIC LUPUS ERYTHEMATOSUS
BIOCARTA FREE PATHWAY
CORUM NFKB1-NFKB2-RELA-RELB COMPLEX
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 UP
NAKAYAMA SOFT TISSUE TUMORS PCA1 UP
NIELSEN MALIGNAT FIBROUS HISTIOCYTOMA UP
BROWNE HCMV INFECTION 8HR UP
ISHIKAWA STING SIGNALING
FOSTER INFLAMMATORY RESPONSE LPS DN
TAVOR CEBPA TARGETS UP
GAURNIER PSMD4 TARGETS
REACTOME P53 INDEPENDENT DNA DAMAGE RESPONSE
FARMER BREAST CANCER CLUSTER 1
GRANDVAUX IFN RESPONSE NOT VIA IRF3
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA UP
MARKEY RB1 CHRONIC LOF DN
NCI CD8TCRDOWNSTREAMPATHWAY
GESERICK TERT TARGETS DN
NOJIMA SFRP2 TARGETS DN
KEGG T CELL RECEPTOR SIGNALING PATHWAY
AMIT SERUM RESPONSE 120 MCF10A
TAVOR CEBPA TARGETS DN
REACTOME REGULATION OF ORNITHINE DECARBOXYLASE
LEE LIVER CANCER MYC E2F1 UP
NCI IL1PATHWAY
CORUM IFP35-NMI COMPLEX
GEISS RESPONSE TO DSRNA UP
GRAHAM CML DIVIDING VS NORMAL QUIESCENT DN
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 1
GRANDVAUX IRF3 TARGETS UP
ZHU CMV ALL UP
GRUETZMANN PANCREATIC CANCER UP
NCI SCF BETA TRCP MEDIATED DEGRADATION OF EMI1
KEGG PROTEASOME
NCI REGULATION OF ACTIVATED PAK 2P34 BY PROTEASOME MEDIATED DEGRADATION1
NATSUME RESPONSE TO INTERFERON BETA UP
AMIT DELAYED EARLY GENES
KEGG CYTOKINE CYTOKINE RECEPTOR INTERACTION
NOJIMA SFRP2 TARGETS UP
CHEN HOXA5 TARGETS 6HR UP
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER UP
NCI NFKAPPABATYPICALPATHWAYBCL3
WU CELL MIGRATION
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 9
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 10D UP
WALLACE PROSTATE CANCER RACE UP
NETPATH IL 7 PATHWAY DOWN
WIELAND UP BY HBV INFECTION
BIOCARTA IL12 PATHWAY
TSAI RESPONSE TO RADIATION THERAPY
UROSEVIC RESPONSE TO IMIQUIMOD
BROWNE HCMV INFECTION 30MIN UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 3D UP
HARRIS HYPOXIA
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS DN
NETPATH B CELL RECEPTOR PATHWAY DOWN
XU RESPONSE TO TRETINOIN AND NSC682994 UP
SOUCEK MYC TARGETS
BILBAN B CLL LPL DN
ZHAN MULTIPLE MYELOMA LB DN
KEGG AUTOIMMUNE THYROID DISEASE
LIANG SILENCED BY METHYLATION 2
DAUER STAT3 TARGETS UP
DER IFN ALPHA RESPONSE UP
ZUCCHI METASTASIS UP
LEE LIVER CANCER ACOX1 UP
CORUM INTERFERON-STIMULATED GENE FACTOR 3 TRANSCRIPTION COMPLEX ISGF3
EINAV INTERFERON SIGNATURE IN CANCER
PELLICCIOTTA HDAC IN ANTIGEN PRESENTATION DN
MCLACHLAN DENTAL CARIES DN
LEI MYB TARGETS
KEGG ALLOGRAFT REJECTION
BROWNE HCMV INFECTION 4HR UP
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
ZHU CMV 8 HR UP
BIOCARTA INFLAM PATHWAY
SANA TNF SIGNALING UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 8D UP
NCI IL27PATHWAY
SCHUETZ BREAST CANCER DUCTAL INVASIVE UP
ONDER CDH1 TARGETS 2 DN
NCI REGULATION OF ORNITHINE DECARBOXYLASE ODC
REACTOME STABILIZATION OF P53
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
CASTELLANO NRAS TARGETS UP
KEGG HEMATOPOIETIC CELL LINEAGE
SATO SILENCED BY METHYLATION IN PANCREATIC CANCER 2
KEGG CHEMOKINE SIGNALING PATHWAY
FUJII YBX1 TARGETS UP
JISON SICKLE CELL DISEASE UP
BIOCARTA CTLA4 PATHWAY
NCI IL12 STAT4PATHWAY
TARTE PLASMA CELL VS PLASMABLAST UP
DASU IL6 SIGNALING UP
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
ZHAN MULTIPLE MYELOMA HP UP
ZUCCHI METASTASIS DN
NCI REGULATION OF ACTIVATED PAK 2P34 BY PROTEASOME MEDIATED DEGRADATION
LU IL4 SIGNALING
KEGG ANTIGEN PROCESSING AND PRESENTATION
HOFFMANN PRE BI TO LARGE PRE BII LYMPHOCYTE DN
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
streptococcus pyogenesmycobacterium tuberculosisescherichia coliGeneSet Name
0.03392 0.00534 0.00001NETPATH_TNF_ALPHA_PATHWAY_UP
0.01602 0.00008 0.00000NETPATH_IL_2_PATHWAY_UP
0.03192 0.00602 0.00000NETPATH_IL_1_PATHWAY_UP
0.02708 0.00019 0.00023NETPATH_KIT_RECEPTOR_PATHWAY_UP
0.00014 0.00126 0.00000NCI_IL23PATHWAY
0.00000 0.00051 0.00000NCI_IL12_2PATHWAY
0.03974 0.00000 0.00001NETPATH_IL_5_PATHWAY_UP
0.08745 0.00218 0.00228NETPATH_B_CELL_RECEPTOR_PATHWAY_UP
0.00471 0.00000 0.00000NETPATH_IL_4_PATHWAY_DOWN
0.04416 0.00856 0.00000NETPATH_IL_7_PATHWAY_UP
0.01652 0.00000 0.01389GERY_CEBP_TARGETS
0.00000 0.00288 0.00785NCI_IL6_7PATHWAY
0.00095 0.00171 0.00000NETPATH_IL_3_PATHWAY_UP
0.02244 0.00814 0.00133SA_MMP_CYTOKINE_CONNECTION
0.00000 0.01857 0.00964NCI_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL
0.00001 0.00000 0.00000NETPATH_IL_6_PATHWAY_UP
0.03771 0.00336 0.00002BIOCARTA_IL10_PATHWAY
0.00203 0.02317 0.01812RASHI_RESPONSE_TO_IONIZING_RADIATION_6
0.03626 0.14979 0.00008BIOCARTA_STEM_PATHWAY
0.00011 0.08229 0.00028NETPATH_IL_9_PATHWAY_UP
0.16684 0.00073 0.00000BIOCARTA_NFKB_PATHWAY
0.17839 0.00132 0.00000MAHAJAN_RESPONSE_TO_IL1A_UP
0.00482 0.06335 0.02803BIOCARTA_IL6_PATHWAY
0.01019 0.02321 0.00002KEGG_GRAFT_VERSUS_HOST_DISEASE
0.02304 0.00000 0.00000LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.00396 0.00000 0.00000KRASNOSELSKAYA_ILF3_TARGETS_UP
0.00865 0.00787 0.08644NCI_HOST_INTERACTIONS_OF_HIV_FACTORS
0.00000 0.00000 0.00000RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.00000 0.00000 0.00000RADAEVA_RESPONSE_TO_IFNA1_UP
0.14622 0.17658 0.19679CORUM_PA28_COMPLEX
0.00020 0.00000 0.00001BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX
0.19933 0.00002 0.03400MUNSHI_MULTIPLE_MYELOMA_UP
0.02955 0.01422 0.09524NCI_SCF_SKP2__MEDIATED_DEGRADATION_OF_P27_P21
0.07566 0.07509 0.15073REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21
0.11415 0.00000 0.00000THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.13253 0.00000 0.00220TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.00204 0.00000 0.02437LENAOUR_DENDRITIC_CELL_MATURATION_DN
0.05930 0.00000 0.00000HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.00000 0.00000 0.00000MARKEY_RB1_ACUTE_LOF_UP
0.03169 0.04489 0.17729SCHEIDEREIT_IKK_INTERACTING_PROTEINS
0.01569 0.00000 0.00144XU_AKT1_TARGETS_6HR
0.00003 0.01142 0.03522POOLA_INVASIVE_BREAST_CANCER_UP
0.00000 0.00067 0.00647LIU_VAV3_PROSTATE_CARCINOGENESIS_UP
0.00007 0.00176 0.00000REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES
0.00000 0.00000 0.00000SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP
0.13305 0.00051 0.00464BROWNE_HCMV_INFECTION_6HR_UP
0.00003 0.00000 0.00000DAUER_STAT3_TARGETS_DN
0.08751 0.03099 0.05932BIOCARTA_RANKL_PATHWAY
0.00000 0.00000 0.00000MCLACHLAN_DENTAL_CARIES_UP
0.01122 0.00058 0.02432WHITESIDE_CISPLATIN_RESISTANCE_UP
0.00019 0.00095 0.10124HOSHIDA_LIVER_CANCER_SUBCLASS_S1
0.06782 0.05412 0.06500DIRMEIER_LMP1_RESPONSE_LATE_DN
0.01561 0.00014 0.00843LEE_LIVER_CANCER_E2F1_UP
0.00113 0.00000 0.00002HELLER_SILENCED_BY_METHYLATION_UP
0.00016 0.00000 0.00000BOWIE_RESPONSE_TO_TAMOXIFEN
0.06782 0.00000 0.00000ZHOU_INFLAMMATORY_RESPONSE_LPS_UP
0.05508 0.07952 0.00006SMID_BREAST_CANCER_LUMINAL_B_DN
0.00000 0.00021 0.00769ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP
0.03166 0.00001 0.06057FURUKAWA_DUSP6_TARGETS_PCI35_UP
0.00000 0.01587 0.00800REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL
0.16321 0.06627 0.00402BIOCARTA_IL17_PATHWAY
0.01128 0.00000 0.00000VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.00074 0.00000 0.00002BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.01622 0.10331 0.01653REACTOME_G_ALPHA_I_SIGNALLING_EVENTS
0.00455 0.00000 0.00000TIAN_TNF_SIGNALING_VIA_NFKB
0.02106 0.00035 0.00005HUMMEL_BURKITTS_LYMPHOMA_DN
0.00011 0.00000 0.00000KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.01028 0.00789 0.09578NCI_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G
0.00828 0.03548 0.11780GOLUB_ALL_VS_AML_DN
0.17781 0.05523 0.00288CORUM_NFKB1-NFKB2-REL-RELA-RELB_COMPLEX
0.01881 0.00348 0.13163NCI_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX
0.05939 0.00023 0.04462LEE_EARLY_T_LYMPHOCYTE_DN
0.04595 0.00030 0.00046HUANG_DASATINIB_RESISTANCE_UP
0.14412 0.00000 0.00000HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.01557 0.00000 0.00000MISSIAGLIA_REGULATED_BY_METHYLATION_UP
0.00955 0.03373 0.03091KEGG_PRIMARY_IMMUNODEFICIENCY
0.00000 0.00000 0.00000ZHANG_INTERFERON_RESPONSE
0.02148 0.00000 0.00015CHANG_IMMORTALIZED_BY_HPV31_DN
0.01756 0.04602 0.01024SIMBULAN_UV_RESPONSE_NORMAL_UP
0.00010 0.00000 0.02879KHETCHOUMIAN_TRIM24_TARGETS_UP
0.00000 0.00000 0.00004KIM_LRRC3B_TARGETS
0.13522 0.08089 0.00108DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP
0.05659 0.01169 0.00140CORUM_PA28-20S_PROTEASOME
0.00011 0.00000 0.00057ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP
0.02986 0.00000 0.12734RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
0.00388 0.13686 0.00439BIOCARTA_TH1TH2_PATHWAY
0.00073 0.00004 0.01475TSAI_DNAJB4_TARGETS_UP
0.06972 0.00014 0.04300MORI_PRE_BI_LYMPHOCYTE_DN
0.00032 0.00000 0.00000DER_IFN_BETA_RESPONSE_UP
0.19929 0.00000 0.00002DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
0.14953 0.04845 0.02986NETPATH_IL_6_PATHWAY
0.04336 0.06095 0.10376GILDEA_METASTASIS
0.10732 0.00486 0.00089AMIT_EGF_RESPONSE_20_HELA
0.04180 0.17731 0.04486GALI_TP53_TARGETS_APOPTOTIC_UP
0.00580 0.00000 0.10451TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN
0.11216 0.02752 0.11100HOUSTIS_ROS
0.00023 0.00000 0.00000BASSO_CD40_SIGNALING_UP
0.13526 0.00127 0.00002MARZEC_IL2_SIGNALING_UP
0.02720 0.04300 0.10036BIOCARTA_BLYMPHOCYTE_PATHWAY
0.00075 0.02453 0.05549BOYLAN_MULTIPLE_MYELOMA_C_D_DN
0.02328 0.00019 0.00496WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.02682 0.10873 0.00219WU_HBX_TARGETS_2_DN
0.01593 0.00004 0.00000MAHADEVAN_RESPONSE_TO_MP470_UP
0.17999 0.19850 0.09154CORUM_UBIQUITIN_E3_LIGASE_TRIM25_DDX58
0.00464 0.15473 0.13855SMID_BREAST_CANCER_NORMAL_LIKE_UP
0.02287 0.01104 0.00058BIOCARTA_TID_PATHWAY
0.01314 0.00002 0.00000KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.00000 0.00000 0.00000SANA_RESPONSE_TO_IFNG_UP
0.01918 0.00468 0.04833REACTOME_VIF_MEDIATED_DEGRADATION_OF_APOBEC3G
0.00061 0.00007 0.00028KEGG_LEISHMANIA_INFECTION
0.00004 0.07526 0.05581BOYLAN_MULTIPLE_MYELOMA_PCA1_UP
0.02757 0.01699 0.15918LIANG_SILENCED_BY_METHYLATION_UP
0.02608 0.02502 0.00002BIOCARTA_DEATH_PATHWAY
0.00000 0.00000 0.00000SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.04289 0.18546 0.17607DAZARD_UV_RESPONSE_CLUSTER_G24
0.05533 0.00000 0.00000GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.00624 0.00026 0.11638PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION
0.00000 0.00000 0.00000MOSERLE_IFNA_RESPONSE
0.02264 0.00551 0.03879NCI_UBIQUITIN_DEPENDENT_DEGRADATION_OF_CYCLIN_D1
0.00000 0.00000 0.00011FOSTER_INFLAMMATORY_RESPONSE_LPS_UP
0.18436 0.10630 0.00194BIOCARTA_ASBCELL_PATHWAY
0.00000 0.00016 0.15541RODWELL_AGING_KIDNEY_UP
0.02844 0.12410 0.02526INGA_TP53_TARGETS
0.04007 0.00059 0.00000KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY
0.00756 0.15036 0.00116LINDSTEDT_DENDRITIC_CELL_MATURATION_C
0.00223 0.00002 0.08736MORI_IMMATURE_B_LYMPHOCYTE_UP
0.00000 0.00000 0.08966HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.14957 0.00018 0.05426BIOCARTA_TOLL_PATHWAY
0.12740 0.03451 0.00004AMIT_EGF_RESPONSE_120_MCF10A
0.01025 0.00002 0.00008BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
0.01493 0.01224 0.11597NCI_UBIQUITIN_MEDIATED_DEGRADATION_OF_PHOSPHORYLATED_CDC25A
0.10953 0.04958 0.01398NCI_ACTIVATION_OF_PRO_CASPASE_8
0.19931 0.00000 0.00005PRAMOONJAGO_SOX4_TARGETS_UP
0.11209 0.02988 0.04832NETPATH_IL_5_PATHWAY
0.00608 0.09603 0.01464BIOCARTA_NO2IL12_PATHWAY
0.08562 0.00000 0.00009TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP
0.00000 0.00000 0.00515BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN
0.00000 0.00000 0.00000ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP
0.04812 0.00165 0.03638MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN
0.00784 0.13556 0.00011TENEDINI_MEGAKARYOCYTE_MARKERS
0.00032 0.00000 0.00000LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.00273 0.07785 0.06043HOFMANN_CELL_LYMPHOMA_DN
0.00399 0.01956 0.19860MORI_LARGE_PRE_BII_LYMPHOCYTE_DN
0.14382 0.06625 0.00330XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP
0.05474 0.00137 0.00003BIOCARTA_NKT_PATHWAY
0.00000 0.00000 0.00000BROWNE_INTERFERON_RESPONSIVE_GENES
0.00018 0.00051 0.13298REACTOME_SIGNALING_IN_IMMUNE_SYSTEM
0.00062 0.00015 0.00141ROETH_TERT_TARGETS_UP
0.10462 0.06313 0.13309ST_TYPE_I_INTERFERON_PATHWAY
0.00429 0.01362 0.06884KAAB_FAILED_HEART_VENTRICLE_DN
0.02604 0.00060 0.00000KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.03178 0.00021 0.00002OSADA_ASCL1_TARGETS_DN
0.06138 0.00092 0.00003GILMORE_CORE_NFKB_PATHWAY
0.10005 0.00000 0.00000NUYTTEN_EZH2_TARGETS_UP
0.02575 0.00002 0.00000DUTTA_APOPTOSIS_VIA_NFKB
0.01117 0.01147 0.00003BIOCARTA_IL22BP_PATHWAY
0.13519 0.00018 0.00200DELYS_THYROID_CANCER_UP
0.02653 0.00008 0.00126TSAI_RESPONSE_TO_IONIZING_RADIATION
0.00616 0.00000 0.00000DIRMEIER_LMP1_RESPONSE_EARLY
0.00000 0.00000 0.00000DER_IFN_GAMMA_RESPONSE_UP
0.00394 0.00469 0.00010KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION
0.01662 0.00707 0.13037NCI_VPU_MEDIATED_DEGRADATION_OF_CD4
0.00004 0.00000 0.00000BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS
0.10876 0.06290 0.00130BIOCARTA_FREE_PATHWAY
0.15921 0.04157 0.01451CORUM_NFKB1-NFKB2-RELA-RELB_COMPLEX
0.18510 0.00000 0.01985RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
0.00012 0.00000 0.04537NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP
0.01028 0.02002 0.00438NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.14519 0.00000 0.00256BROWNE_HCMV_INFECTION_8HR_UP
0.08747 0.00865 0.00301ISHIKAWA_STING_SIGNALING
0.00568 0.00000 0.00000FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.00445 0.00011 0.00020TAVOR_CEBPA_TARGETS_UP
0.00000 0.00000 0.00000GAURNIER_PSMD4_TARGETS
0.01656 0.01493 0.13847REACTOME_P53_INDEPENDENT_DNA_DAMAGE_RESPONSE
0.00000 0.00000 0.00000FARMER_BREAST_CANCER_CLUSTER_1
0.00000 0.00000 0.00002GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3
0.08503 0.00092 0.10200PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP
0.00039 0.01556 0.09710MARKEY_RB1_CHRONIC_LOF_DN
0.04301 0.06592 0.02808NCI_CD8TCRDOWNSTREAMPATHWAY
0.01538 0.00002 0.00083GESERICK_TERT_TARGETS_DN
0.01391 0.00051 0.00025NOJIMA_SFRP2_TARGETS_DN
0.15091 0.03737 0.10958KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
0.09332 0.00013 0.00011AMIT_SERUM_RESPONSE_120_MCF10A
0.16079 0.00294 0.14255TAVOR_CEBPA_TARGETS_DN
0.03648 0.02161 0.11712REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE
0.01825 0.00022 0.08000LEE_LIVER_CANCER_MYC_E2F1_UP
0.19947 0.01300 0.00686NCI_IL1PATHWAY
0.17145 0.13999 0.13250CORUM_IFP35-NMI_COMPLEX
0.01876 0.00000 0.00000GEISS_RESPONSE_TO_DSRNA_UP
0.19908 0.00000 0.00000GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.01687 0.00666 0.00653SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1
0.00549 0.00065 0.00002GRANDVAUX_IRF3_TARGETS_UP
0.06342 0.00000 0.00000ZHU_CMV_ALL_UP
0.02643 0.00008 0.02087GRUETZMANN_PANCREATIC_CANCER_UP
0.01835 0.00570 0.08611NCI_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1
0.01420 0.00367 0.00631KEGG_PROTEASOME
0.01268 0.00809 0.13298NCI_REGULATION_OF_ACTIVATED_PAK_2P34_BY_PROTEASOME_MEDIATED_DEGRADATION1
0.11227 0.00485 0.06156NATSUME_RESPONSE_TO_INTERFERON_BETA_UP
0.11718 0.00001 0.00082AMIT_DELAYED_EARLY_GENES
0.00010 0.00225 0.00000KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION
0.08281 0.00000 0.00018NOJIMA_SFRP2_TARGETS_UP
0.12534 0.00079 0.13852CHEN_HOXA5_TARGETS_6HR_UP
0.01265 0.00000 0.01400SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.01125 0.01619 0.00288NCI_NFKAPPABATYPICALPATHWAY
0.05956 0.02779 0.00033WU_CELL_MIGRATION
0.03584 0.00294 0.05591YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9
0.00854 0.00000 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP
0.00000 0.00000 0.00004WALLACE_PROSTATE_CANCER_RACE_UP
0.03184 0.13295 0.00034NETPATH_IL_7_PATHWAY_DOWN
0.00000 0.00000 0.00002WIELAND_UP_BY_HBV_INFECTION
0.01228 0.07495 0.14878BIOCARTA_IL12_PATHWAY
0.02614 0.00000 0.00005TSAI_RESPONSE_TO_RADIATION_THERAPY
0.00001 0.00000 0.00000UROSEVIC_RESPONSE_TO_IMIQUIMOD
0.19834 0.00010 0.07149BROWNE_HCMV_INFECTION_30MIN_UP
0.00000 0.00000 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
0.15102 0.00067 0.00034HARRIS_HYPOXIA
0.00016 0.00000 0.00002FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
0.03148 0.19466 0.04764NETPATH_B_CELL_RECEPTOR_PATHWAY_DOWN
0.00327 0.02074 0.00009XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP
0.00021 0.02521 0.00037SOUCEK_MYC_TARGETS
0.04441 0.01866 0.14289BILBAN_B_CLL_LPL_DN
0.00000 0.00000 0.00002ZHAN_MULTIPLE_MYELOMA_LB_DN
0.00071 0.00343 0.00009KEGG_AUTOIMMUNE_THYROID_DISEASE
0.00099 0.00000 0.00000LIANG_SILENCED_BY_METHYLATION_2
0.00038 0.00000 0.00003DAUER_STAT3_TARGETS_UP
0.00000 0.00000 0.00000DER_IFN_ALPHA_RESPONSE_UP
0.01566 0.03573 0.11573ZUCCHI_METASTASIS_UP
0.17117 0.00473 0.13289LEE_LIVER_CANCER_ACOX1_UP
0.15209 0.13577 0.15759CORUM_INTERFERON-STIMULATED_GENE_FACTOR_3_TRANSCRIPTION_COMPLEX_ISGF3
0.00000 0.00000 0.00000EINAV_INTERFERON_SIGNATURE_IN_CANCER
0.00128 0.00008 0.09136PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN
0.00000 0.00001 0.00002MCLACHLAN_DENTAL_CARIES_DN
0.04500 0.10821 0.01867LEI_MYB_TARGETS
0.03176 0.00549 0.00000KEGG_ALLOGRAFT_REJECTION
0.06323 0.00024 0.00000BROWNE_HCMV_INFECTION_4HR_UP
0.00019 0.00000 0.00000ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.00367 0.00000 0.00000ZHU_CMV_8_HR_UP
0.19333 0.05068 0.00000BIOCARTA_INFLAM_PATHWAY
0.00000 0.00000 0.00000SANA_TNF_SIGNALING_UP
0.00957 0.00000 0.00000TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP
0.00027 0.04359 0.00000NCI_IL27PATHWAY
0.11584 0.00036 0.01672SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
0.16233 0.00500 0.00002ONDER_CDH1_TARGETS_2_DN
0.01121 0.02665 0.11477NCI_REGULATION_OF_ORNITHINE_DECARBOXYLASE__ODC_
0.02658 0.00975 0.17726REACTOME_STABILIZATION_OF_P53
0.09492 0.00000 0.00000HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.00217 0.00316 0.00040CASTELLANO_NRAS_TARGETS_UP
0.00468 0.11260 0.00021KEGG_HEMATOPOIETIC_CELL_LINEAGE
0.07017 0.04041 0.03679SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2
0.01866 0.02902 0.00217KEGG_CHEMOKINE_SIGNALING_PATHWAY
0.05749 0.01288 0.02740FUJII_YBX1_TARGETS_UP
0.00066 0.00000 0.00023JISON_SICKLE_CELL_DISEASE_UP
0.00608 0.02940 0.06958BIOCARTA_CTLA4_PATHWAY
0.00112 0.13077 0.01630NCI_IL12_STAT4PATHWAY
0.13540 0.00261 0.03677TARTE_PLASMA_CELL_VS_PLASMABLAST_UP
0.04449 0.00006 0.00015DASU_IL6_SIGNALING_UP
0.05507 0.00002 0.00000GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.16093 0.00952 0.02203ZHAN_MULTIPLE_MYELOMA_HP_UP
0.01684 0.00039 0.00000ZUCCHI_METASTASIS_DN
0.00873 0.00636 0.06877NCI_REGULATION_OF_ACTIVATED_PAK_2P34_BY_PROTEASOME_MEDIATED_DEGRADATION
0.14418 0.02153 0.00649LU_IL4_SIGNALING
0.00038 0.00022 0.08941KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION
0.18208 0.01462 0.04160HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN